期刊文献+

培高利特对帕金森病大鼠保护作用的初步研究 被引量:1

Primary investigation of protective effect of pergolide on parkinsonian rat
下载PDF
导出
摘要 目的 初步观察培高利特对大鼠黑质多巴胺神经元的保护作用 ,并探讨其可能的机制。方法 通过立体定位注射 6 羟基多巴胺 (6 OHDA)制作帕金森病大鼠模型 ,观察预先注射培高利特对阿朴吗啡诱发的旋转行为及受损侧黑质病理变化的影响。结果 大鼠持续注射培高利特 7d后可明显减轻PD大鼠的旋转行为 ,并对抗 6 OHDA所致黑质多巴胺神经元的减少。而选择性D2 受体拮抗剂氨黄酰基苯甲酰胺化合物 (Sulpiride)可阻断培高利特的保护效应。结论 培高利特对多巴胺神经元具有保护作用 ,其机制可能与刺激多巴胺D2 Objective To investigate whether or not pre treatment with pergolide, could protect rat against 6 hydroxydopamine(6 OHDA) induced injury to dopaminergic(DA) neuron in the substantia nigra.Methods Unilateral PD rat models were made by injecting stereotaxically 6 OHDA.The effects of pre treatment with pergolide on the apomorphine(APO) induced rotational behavior and the pathological changes of substantia nigra on the lesion side were observed.Results Pre treatment with pergolide for 7 days significantly decreased the rotational behavior and the redamage of the DA neurons on the lesion side in PD rat models. Pretreatment with sulpiride,a DA D 2 antagonist,abolished the neuroprotection of pergolide.Conclusion Pergolide could provide neuroprotection to DA neuron, and its mechanism was possibly associated with stimulation of the DA D 2 receptor.
作者 王健 彭国光
出处 《重庆医学》 CAS CSCD 2003年第6期729-731,共3页 Chongqing medicine
关键词 培高利特 帕金森病 多巴胺神经元 D2受体 pergolide Parkinson disease dopamine neuron D 2 receptor
  • 相关文献

参考文献5

  • 1王健.氧化应激与帕金森病研究进展[J].国外医学(内科学分册),2001,28(8):327-330. 被引量:12
  • 2Agid Y,Lovedopa. Is toxicity a myth? 1998[J]. Neurology,2001,57(10 Suppl 3) :46. 被引量:1
  • 3Olanow CW, Jenner P, Brooks D. Dopamine agonists and neuroprotection in Parkinson's disease[J]. Ann Neurol, 1998,44(3 Suppl 1) : 167. 被引量:1
  • 4Iida M, Miyazaki I, Tanaka K,et al. Dopamine D2 receptormediated antioxidant and neuroprotective effects of ropinirole,a dopamine agonist[J]. Brain Res, 1999,838 ( 1-2) : 51. 被引量:1
  • 5Felten DL, Felten SY, Fuller RW, et al. Chronic dietary pegolide preserves nigrostriatal neuronal integrity in aged fischer 344 rats[J]. Neurobiol Ageing, 1992.13 : 339. 被引量:1

二级参考文献20

  • 1Jenner P, Olanow CW. [J]. Ann Neurol, 1998,44(Suppl 1 ): S72-S84. 被引量:1
  • 2Yoritaka A, Hattori N, Uchida K, et al. [J]. Proc Natl Acad Sci USA, 1996,2696-2713. 被引量:1
  • 3Sian J, Dexter DT, Lees AJ, et al. [J]. Ann Neurol,1994,36: 348-355. 被引量:1
  • 4Wullner U, Loschmann PA, Schulz JB, et al. [J].Neuroreport, 1996,7:921-923. 被引量:1
  • 5Chinopoulos C, Adam-Vizi V. [J]. J Neurochem,2001,76(1) :302-306. 被引量:1
  • 6Beal MF. [J]. Ann Neurol, 1998,44(Suppl 1):S110-S114. 被引量:1
  • 7Bolanos JP, Heales SJR, Peuchen S, et al. [J]. Free Radic Biol Med, 1996,21:995-1001. 被引量:1
  • 8Przedborski S, Kostic V,Jackson-Lewss V, et al. [J].J Neurosci, 1992,12:1658-1667. 被引量:1
  • 9Przedborski S, Jackson-Lewss V, Yokoyama R, et al.[J]. Proc Natl Acad Sci USA, 1996,93:4565-4571. 被引量:1
  • 10Rabinovic AD, Lewis DA, Hastings TG. [J]. Neuroscience, 2000,101( 1 ) :67-76. 被引量:1

共引文献11

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部